European Hematology Association - 31st Congress, 2026 (EHA) 11 - 14 June 2026

Efficacy and safety of oral tetrahydrouridine-decitabine (NDec) in adults with sickle cell disease: results from the phase 2, global, randomized, parallel-group ASCENT1 trial

Authors :

Biree Andemariam¹; Priyanka Samal²; Dharmesh Vaghasiya³; Modupe Idowu⁴; Pernille Højlund Jacobsen⁵; Christian Jakob Carlsson5; Raffaella Colombatti⁶

Affiliations

View Details Hide Details

Download poster (.pdf)

Keywords

Sickle Cell Disease

Congress oral presentation

NDec

Are you a healthcare professional?